Dr. Reddy's Laboratories Limited (NSE:DRREDDY)

Dr. Reddy's Laboratories Statistics

Total Valuation

NSE:DRREDDY has a market cap or net worth of INR 953.17 billion. The enterprise value is 948.17 billion.

Market Cap	953.17B
Enterprise Value	948.17B

Important Dates

The next estimated earnings date is Friday, May 9, 2025.

Earnings Date	May 9, 2025
Ex-Dividend Date	Jul 16, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.14%
Shares Change (QoQ)	+0.03%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	595.98M

Valuation Ratios

The trailing PE ratio is 17.76.

PE Ratio	17.76
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	4.48
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 10.91, with an EV/FCF ratio of 87.26.

EV / Earnings	17.66
EV / Sales	3.05
EV / EBITDA	10.91
EV / EBIT	13.41
EV / FCF	87.26

Financial Position

The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.16.

Current Ratio	1.92
Quick Ratio	1.18
Debt / Equity	0.16
Debt / EBITDA	0.59
Debt / FCF	4.70
Interest Coverage	25.48

Financial Efficiency

Return on equity (ROE) is 18.47% and return on invested capital (ROIC) is 13.34%.

Return on Equity (ROE)	18.47%
Return on Assets (ROA)	10.32%
Return on Invested Capital (ROIC)	13.34%
Return on Capital Employed (ROCE)	20.19%
Revenue Per Employee	11.51M
Profits Per Employee	1.98M
Employee Count	27,048
Asset Turnover	0.73
Inventory Turnover	1.91

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -5.35% in the last 52 weeks. The beta is 0.35, so NSE:DRREDDY's price volatility has been lower than the market average.

Beta (5Y)	0.35
52-Week Price Change	-5.35%
50-Day Moving Average	1,186.49
200-Day Moving Average	1,282.31
Relative Strength Index (RSI)	43.49
Average Volume (20 Days)	2,092,684

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, NSE:DRREDDY had revenue of INR 311.31 billion and earned 53.68 billion in profits. Earnings per share was 64.35.

Revenue	311.31B
Gross Profit	184.65B
Operating Income	70.49B
Pretax Income	72.75B
Net Income	53.68B
EBITDA	85.56B
EBIT	70.49B
Earnings Per Share (EPS)	64.35

Balance Sheet

The company has 59.92 billion in cash and 51.09 billion in debt, giving a net cash position of 8.84 billion.

Cash & Cash Equivalents	59.92B
Total Debt	51.09B
Net Cash	8.84B
Net Cash Per Share	n/a
Equity (Book Value)	321.57B
Book Value Per Share	381.36
Working Capital	121.07B

Cash Flow

In the last 12 months, operating cash flow was 35.95 billion and capital expenditures -25.09 billion, giving a free cash flow of 10.87 billion.

Operating Cash Flow	35.95B
Capital Expenditures	-25.09B
Free Cash Flow	10.87B
FCF Per Share	n/a

Margins

Gross margin is 59.31%, with operating and profit margins of 22.64% and 17.24%.

Gross Margin	59.31%
Operating Margin	22.64%
Pretax Margin	23.37%
Profit Margin	17.24%
EBITDA Margin	27.48%
EBIT Margin	22.64%
FCF Margin	3.49%

Dividends & Yields

This stock pays an annual dividend of 8.00, which amounts to a dividend yield of 0.70%.

Dividend Per Share	8.00
Dividend Yield	0.70%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	12.41%
Buyback Yield	-0.14%
Shareholder Yield	0.56%
Earnings Yield	5.63%
FCF Yield	1.14%

Stock Splits

The last stock split was on October 28, 2024. It was a forward split with a ratio of 5.

Last Split Date	Oct 28, 2024
Split Type	Forward
Split Ratio	5

Scores

NSE:DRREDDY has an Altman Z-Score of 6.27.

Altman Z-Score	6.27
Piotroski F-Score	n/a